Solutions
opening the door to a total new modality in the field of blood flow diagnostics
The two initial product lines are based on a developed imaging software technology for advanced blood flow analysis from computed tomography (CT) scans of the heart. While CT cannot measure blood flow, our technology can process clinical-standard CT images to retroactively calculate the flow field – opening the door to a total new modality in the field of blood flow diagnostics. In the clinical verification process, an extensive need for improved blood flow diagnostics was early identified by the team in two areas: Atrial Fibrillation and Valve Disease.
Product line: Atrial Fibrillation
The Atrial Fibrillation Application is designed to quantify blood flow stagnation -providing doctors with additional information about the risk of heart embolism and stroke in atrial fibrillation or atrial-related pathology. The application also enables various user-interactive scenarios which gives the doctor a broad set of disease scenarios to support risk stratification and treatment options.
Product line: Valve Disease
The valve disease application is designed to enable virtual interactive placement of different types, positions, and sizes of prosthetic heart valves prior to planned valve surgery or intervention. The software allows testing the placement of virtual valve models on cardiac CT images in an interactive environment. These scenarios can assist the surgeon or interventionalist in considering different options before the procedure.
With global market ambitions, cutting-edge innovations, and early market interest, our team is continuously engaging in dialogue with partners, collaborators, investors, and talents who can strengthen the company and accelerate the delivery of patient benefits. Please don’t hesitate to reach out.